Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Recs

0
Player Avatar vgaymer (24.01) Submitted: 4/12/2009 4:55:58 PM : Outperform Start Price: $15.67 VIVO Score: -34.81

msn screen:

5 year div. growth >= 20 %
annual eps growth >= 25%
debt/eq <= 0.5
current dividend >= 2.5%

Featured Broker Partners


Advertisement